[1]McPherron A C, Lawler A M, Lee S J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 1997, 387(6628):83-90.[2]Vissac B. Research activities on hereditary muscular hypertrophy. In Current Topics in Veterinary Medicine and Animal Science XVI: Muscle Hypertrophy of genetic origin and its use to improve beef production. (Ed. by King JWB , Ménissier F). Martinus Nijhoff Publishers, The Hague, 1982: 3-20.[3]Grobet L, Martin L J, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Ménissier F, Massabanda J, Fries R, Hanset R, Georges M. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genetics, 1997, 17(1):71-74.[4]Argilés J M, Orpí M, Busquets S, López-Soriano F J. Myostatin: more than just a regulator of muscle mass. Drug Discovery Today, 2012, 17(13-14):702-709.[5]Elkasrawy M N, Hamrick M W. Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. Journal of Musculoskeletal and Neuronal Interactions. 2010, 10(1): 56-63.[6]Peiris H N, Mitchell M D. The expression and potential functions of placental myostatin. Placenta, 2012, 33(11):902-907.[7]Georges M. When Less Means More: Impact of Myostatin in Animal Breeding. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, 2010, 10, 240-248.[8]Rodgers B D, Garikipati D K. Clinical, agricultural, and evolutionary biology of myostatin: a comparative review. Endocrine Reviews 2008 , 29(5):513-534.[9]Menissier F. General survey of the effect of double muscling on cattle performance. Current Topics in Veterinary Medicine and Animal Science XVI: Muscle Hypertrophy of Genetic Origin and Its Use to Improve Beef Production. (Ed. by King JWB, Menissier F). Martinus Nijhoff Publishers, The Hague, 1982: 23-53.[10]Shahin K A, Berg R T. Growth patterns of muscle, fat and bone, and carcass composition of double muscled and normal cattle. Canadian Journal of Animal Science, 1985: 65:279-293.[11]Vitt U A, Hsu S Y, Hsueh A J. Evolution and classification of cystine knot-containing hormones and related extracellular signaling molecules. Molecular Endocrinology, 2001, 15(5): 681-694.[12]Starck C S, Sutherland-Smith A J. The C313Y Piedmontese mutation decreases myostatin covalent dimerisation and stability. The C313Y Piedmontese mutation decreases myostatin covalent dimerisation and stability. BMC Research Notes, 2011,24(4): 442.[13]Anderson S B, Goldberg A L, Whitman M. Identification of a novel pool of extracellular pro-myostatin in skeletal muscle. Journal of Biological Chemistry, 2008 , 283(11):7027-7035.[14]Wolfman N M, McPherron A C, Pappano W N, Davies M V, Song K, Tomkinson K N, Wright J F, Zhao L, Sebald S M, Greenspan D S, Lee S J. Activation of latent myostatin by the BMP-1/tolloid family of metalloproteinases. Proceedings of the National Academy of Sciences of the United States, 2003, 100(26):15842-15846.[15]Thies R S, Chen T, Davies M V, Tomkinson K N, Pearson A A, Shakey Q A, Wolfman N M. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors, 2001,18(4):251-259.[16]Jiang M S, Liang L F, Wang S, Ratovitski T, Holmstrom J, Barker C, Stotish R. Characterization and identification of the inhibitory domain of GDF-8 propeptide. Biochemical Biophysical Research Communications, 2004, 12;315(3):525-531.[17]Cash J N, Rejon C A, McPherron A C, Bernard D J, Thompson T B. The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding. EMBO Journal, 2009, 28(17): 2662-2676.[18]Hill J J, Davies M V, Pearson A A, Wang J H, Hewick R M, Wolfman N M, Qiu Y. The myostatin propeptide and the follistatin-related gene are inhibitory binding proteins of myostatin in normal serum. Journal of Biological Chemistry, 2002 ,277(43): 40735-40741.[19]Szláma G, Trexler M, Patthy L. Latent myostatin has significant activity and this activity is controlled more efficiently by WFIKKN1 than by WFIKKN2. FEBS Journal, 2013, 280(16):3822-3839.[20]Yasaka N, Suzuki K, Kishioka Y, Wakamatsu J I, Nishimura T. Laminin binds to myostatin and attenuates its signaling. Journal of Animal Science,2013, 84:663-668.[21]Sharma M, Kambadur R, Matthews K G, Somers W G, Devlin G P, Conaglen J V, Fowke P J, Bass J J. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. Journal of Cellular Physiology, 1999, 180(1):1-9.[22]Wong C L, Huang Y Y, Ho W K, Poon H K, Cheung P L, Chow P H. Growth-differentiation factor-8 (GDF-8) in the uterus: its identification and functional significance in the golden hamster. Reprod Biology Endocrinology, 2009, 7:134.[23]Iwasaki S, Miyake M, Watanabe H, Kitagawa E, Watanabe K, Ohwada S, Kitazawa H, Rose MT, Aso H. Expression of myostatin in neural cells of the olfactory system. Molecular Neurobiology, 2013 ,47(1):1-8. [24]Manickam R, Pena R N, Whitelaw C B. Mammary gland differentiation inversely correlates with GDF-8 expression. Molecular Reproduction and Development, 2008 , 75(12):1783-1788.[25]Ji S, Losinski R L, Cornelius S G, Frank G R, Willis G M, Gerrard D E, Depreux F F, Spurlock M E. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. American Journal of Physiology, 1998, 275(4): 1265-1273.[26]Jiao J, Yuan T, Zhou Y, Xie W, Zhao Y, Zhao J, Ouyang H, Pang D. Analysis of myostatin and its related factors in various porcine tissues. Journal of Animal Science, 2011, 89(10):3099-3106.[27]Gao F, Kishida T, Ejima A, Gojo S, Mazda O. Myostatin acts as an autocrine/paracrine negative regulator in myoblast differentiation from human induced pluripotent stem cells. Biochemical and Biophysical Research Communications, 2013 ,431(2):309-314.[28]Chen Y, Ye J, Cao L, Zhang Y, Xia W, Zhu D. Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells. International Journal of Biochemistry & Cell Biology, 2010, 42(12):2072-2081.[29]Taylor W E, Bhasin S, Artaza J, Byhower F, Azam M, Willard D H Jr, Kull F C Jr, Gonzalez-Cadavid N. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. American Journal of Physiology-Endocrinology and Metabolism, 2001, 280(2):E221-228.[30]Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, Kambadur R. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. Journal of Biological Chemistry, 2000, 275(51):40235-40243.[31]Lee J Y, Hopkinson N S, Kemp P R. Myostatin induces autophagy in skeletal muscle in vitro. Biochemical and Biophysical Research Communications, 2011, 415(4):632-636.[32]Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. Journal of Biological Chemistry, 2002, 277(51): 49831-49840.[33]Yang W, Chen Y, Zhang Y, Wang X, Yang N, Zhu D. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression. Cancer Research, 2006, 66(3):1320-1326.[34]Zimmers T A, Davies M V, Koniaris L G, Haynes P, Esquela A F, Tomkinson K N, McPherron A C, Wolfman N M, Lee S J. Induction of cachexia in mice by systemi-cally administered myostatin. Science, 2002,296 :1486-1488.[35]McCroskery S, Thomas M, Platt L, Hennebry A, Nishimura T, McLeay L, Sharma M, Kambadur R. Improved muscle healing through enhanced regeneration and reduced fibrosis in myostatin-null mice. Journal of Cell Science, 2005, 118(15):3531-3541.[36]Nozaki M, Li Y, Zhu J, Ambrosio F, Uehara K, Fu F H, Huard J. Improved muscle healing after contusion injury by the inhibitory effect of suramin on myostatin, a negative regulator of muscle growth. American Journal of Sports Medicine, 2008, 36(12):2354-2362.[37]Allen D L, Unterman T G. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. American Journal of Physiology-Cell Physiology, 2007, 292(1): C188-199.[38]Reardon K A, Davis J, Kapsa R M, Choong P, Byrne E. Myostatin, insulin-like growth factor-1, and leukemia inhibitory factor mRNAs are upregulated in chronic human disuse muscle atrophy. Muscle Nerve, 2001, 24: 893-899.[39]Matsakas A, Bozzo C, Cacciani N, Caliaro F, Reggiani C, Mascarello F, Patruno M. Effect of swimming on myostatin expression in white and red gastrocne-mius muscle and in cardiac muscle of rats. Experimental Physiology, 2006, 91: 983-994.[40]Zhang C, McFarlane C, Lokireddy S, Bonala S, Ge X, Masuda S, Gluckman P D, Sharma M, Kambadur R. Myostatin-deficient mice exhibit reduced insulin resistance through activating the AMP-activated protein kinase signalling pathway. Diabetologia, 2011, 54(6):1491-1501. [41]Elliott B, Renshaw D, Getting S, Mackenzie R. The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiology (Oxf), 2012, 205(3):324-340.[42]Fernández-Solà J, Lluis M, Sacanella E, Estruch R, Antúnez E, Urbano-Márquez A. Increased myostatin activity and decreased myocyte proliferation in chronic alcoholic cardiomyopathy. Alcoholism: Clinical and Experimental Research, 2011, 35(7): 1220-1229. [43]George I, Bish L T, Kamalakkannan G, Petrilli C M, Oz M C, Naka Y, Sweeney H L, Maybaum S. Myostatin activation in patients with advanced heart failure and after mechanical unloading. European Journal of Heart Failure, 2010, 12(5):444-453.[44]Bish L T, George I, Maybaum S, Yang J, Chen J M, Sweeney H L. Myostatin is elevated in congenital heart disease and after mechanical unloading. PLoS One, 2011, 6(9):e23818.[45]Jackson M F, Luong D, Vang D D, Garikipati D K, Stanton J B, Nelson O L, Rodgers B D. The aging myostatin null phenotype: reduced adiposity, cardiac hypertrophy, enhanced cardiac stress response, and sexual dimorphism. Journal of Endocrinology, 2012, 213(3):263-275. [46]Artaza J N, Reisz-Porszasz S, Dow J S, Kloner R A, Tsao J, Bhasin S, Gonzales-Cadavid N F. Alterations in myostatin expression are associated with changes in cardiac left ventricular mass but not ejection fraction in the mouse. Journal of Endocrinology, 2007, 194 :63-76.[47]Reisz-Porszasz S, Bhasin S, Artaza J N, Shen R, Sinha-Hikim I, Hogue A, Fielder T J, Gonzalez-Cadavid N F. Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin. American Journal of Physiology. Endocrinology and Metabolism, 2003, 285 : 876-888.[48]Gruson D, Ahn S A, Ketelslegers J M, Rousseau M F. Increased plasma myostatin in heart failure. European Journal of Heart Failure, 2011, 13(7):734-736. [49]Breitbart A, Auger-Messier M, Molkentin J D, Heineke J. Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting. American Journal of Physiology - Heart and Circulatory Physiology, 2011, 300(6):H1973-1982. [50]McPherron A C, Lee S J. Suppression of body fat accumulation in myostatin-deficient mice. Journal of Clinical Investigation, 2002, 109(5):595-601.[51]Lin J, Arnold H B, Della-Fera M A, Azain M J, Hartzell D L, Baile C A. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochemical and Biophysical Research Communications, 2002, 291(3):701-706.[52]McPherron A C. Metabolic functions of myostatin and Gdf11. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, 2010, 10(4):217-231.[53]Shan T, Liang X, Bi P, Kuang S. Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB Journal, 2013 , 27(5):1981-1989.[54]Braga M, Pervin S, Norris K, Bhasin S, Singh R. Inhibition of in vitro and in vivo brown fat differentiation program by myostatin. Obesity (Silver Spring), 2013, 21(6):1180-1188. [55]Stolz L E, Li D, Qadri A, Jalenak M, Klaman L D, Tobin J F, Administration of myostatin does not alter fat mass in adult mice. Diabetes, Obesity and Metabolism, 2008, 10(2):135-142.[56]Suzuki S T, Zhao B, Yang J. Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin, PPAR-alpha, and PPAR-gamma expressions. Biochemical and Biophysical Research Communications, 2008, 369(2):767-773.[57]Mitchell A D, Wall R J. In vivo evaluation of changes in body composition of transgenic mice expressing the myostatin pro domain using dual energy X-ray absorptiome-try. Growth, Development, and Aging , 2007, 70:25-37.[58]Arounleut P, Bialek P, Liang LF, Upadhyay S, Fulzele S, Johnson M, Elsalanty M, Isales C M, Hamrick M W. A myostatin inhibitor (propeptide-Fc) increases muscle mass and muscle fiber size in aged mice but does not increase bone density or bone strength. Experimental Gerontology, 2013, 48 (9):898-904.[59]Kellum E, Starr H, Arounleut P, Immel D, Fulzele S, Wenger K, Hamrick M W. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone, 2009, 44(1):17-23.[60]Hamrick M W, Pennington C, Byron C D. Bone architecture and disc degeneration in the lumbar spine of mice lacking GDF-8 (myostatin). Journal of Orthopaedic Research, 2003, 21(6): 1025-1032.[61]Mitchell M D, Osepchook C C, Leung K C, McMahon C D, Bass J J. Myostatin is a human placental product that regulates glucose uptake. Journal of Clinical Endocrinology & Metabolism, 2006, 91(4):1434 -1437.[62]Peiris H N, Ponnampalam A P, Osepchook C C, Mitchell M D, Green M P. Placental expression of myostatin and follistatin-like-3 protein in a model develop-mental programming. American Journal of Physiology Endocrinology and Metabolism, 2010,298(4):854-861.[63]Carmela P, Ezra Wiater, Sean M. Smith, and Wylie Vale. Presence, actions, and regulation of myostatin in rat uterus and myometrial cells pasquapina ciarmela, Endocrinology, 2009 ,150(2): 906–914.[64]Culley G. Observations in Livestock. 4th ed., London: G. Woodfall, 1807.[65]Arthur P F. Double muscling in cattle: a review. Australian Journal of Agricultural Research, 1995, 46: 1493-1515.[66]Ménissier F. Present state of knowledge about the genetic determi-nation of muscular hypertrophy or the double muscled trait in cattle. Current Topics in Veterinary Medicine and Animal Science XVI: Muscle Hypertrophy of genetic origin and its use to improve beef production. (Ed. by King JWB, Menissier F). Martinus Nijhoff Publishers, The Hague, 1982: 387-428. [67]Charlier C, Coppieters W, Farnir F, Grobet L, Leroy PL, Michaux C, Mni M, Schwers A, Vanmanshoven P, Hanset R. The mh gene causing double-muscling in cattle maps to bovine Chromosome 2. Mammalian Genome, 1995, 6(11):788-792.[68]Smith T P, Lopez-Corrales N L, Kappes S M, Sonstegard T S. Myostatin maps to the interval containing the bovine mh locus. Mammalian Genome,1997, 8(10):742-744.[69]Karim L, Coppieters W, Grobet L, Valentini A, Georges M. Convenient genotyping of six myostatin mutations causing double-muscling in cattle using a multiplex oligonucleotide ligation assay. Animal Genetics, 2000, 31(6):396-399.[70]Grobet L, Poncelet D, Royo L J, Brouwers B, Pirottin D, Michaux C, Ménissier F, Zanotti M, Dunner S, Georges M. Molecular definition of an allelic series of mutations disrupting the myostatin function and causing double-muscling in cattle. Mammalian Genome, 1998, 9(3): 210-213.[71]Gill J L, Bishop S C, McCorquodale C, Williams J L, Wiener P. Associations between the 11-bp deletion in the myostatin gene and carcass quality in Angus-sired cattle. Animal Genetics, 2009 , 40(1):97-100.[72]Esmailizadeh A K, Bottema C D, Sellick G S, Verbyla A P, Morris C A, Cullen N G, Pitchford W S. Effects of the myostatin F94L substitution on beef traits. Journal of Animal Science, 2008, 86(5):1038-1046.[73]Vankan D M, Waine D R, Fortes M R. Real-time PCR genotyping and frequency of the myostatin F94L mutation in beef cattle breeds. Animal, 2010, 4(4):530-534.[74]Dunner S, Miranda M E, Amigues Y, Cañón J, Georges M, Hanset R, Williams J, Ménissier F. Haplotype diversity of the myostatin gene among beef cattle breeds. Genetics Selection Evolution, 2003, 35(1):103-118.[75]Boman I A, Klemetsdal G, Blichfeldt T, Nafstad O. Våge D I. A frameshift mutation in the coding region of the myostatin gene (MSTN) affects carcass conformation and fatness in Norwe-gian White Sheep (Ovis aries). Animal Genetics, 2009, 40: 418-422.[76]Boman I A, Våge D I. An insertion in the coding region of the myostatin (MSTN) gene affects carcass conformation and fatness in the Norwegian Spaelsau (Ovis aries). BMC Research Notes, 2009, 2:98.[77]Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J Caiment F, Elsen J M, Eychenne F, Larzul C, Lav-ille E, Meish F, Mile nkovic D, Tobin J, Charlier C, Georges M. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genetics, 2006, 38: 813-818.[78]Boman I A, Klemetsdal G, Nafstad O, Blichfeldt T, Våge D I. Impact of two myostatin (MSTN) mutations on weight gain and lamb carcass classification in Norwegian White Sheep (Ovis aries). Genetics Selection Evolution, 2010 , 42:4.[79]Mosher D S, Quignon P, Bustamante C D, Sutter N B, Mellersh C S, Parker H G, Ostrander E A. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs. PLoS Genetics. 2007, 3(5):e79.[80]Shelton G D, Engvall E. Gross muscle hypertrophy in whippet dogs is caused by a mutation in the myostatin gene. Neuromuscul Disord, 2007, 17(9-10):721-722.[81]Schuelke M, Wagner K R, Stolz L E, Hubner C, Riebel T, Komen W, Braun T, Tobin J F, Lee S J. Myostatin mutation associated with gross muscle hypertrophy in a child. New England Journal of Medicine, 2004, 350: 2682-2688.[82]McPherron A C, Lee S J. Double muscling in cattle due to mutations in the myostatin gene. Proceedings of the National Academy of Sciences of the United States, 1997, 94(23):12457-12461.[83]Skipper M. Quantitative genetics: A lean feat — microRNAs and muscle mass. Nature Reviews Genetics, 2006, 7: 491.[84]Grobet L, Pirottin D, Farnir F, Poncelet D, Royo L J, Brouwers B, Christians E, Desmecht D, Coignoul F, Kahn R, Georges M. Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene. Genesis, 2003, 35: 227-238.[85]Hu S, Ni W, Sai W, Zi H, Qiao J, Wang P, Sheng J, Chen C. Knockdown of myostatin expression by RNAi enhances muscle growth in transgenic sheep. PLoS One, 2013, 8(3):e58521.[86]Lee S J, McPherron A C. Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences of the United States, 2001 , 98(16):9306-9311.[87]Nishi M, Yasue A, Nishimatu S, Nohno T, Yamaoka T, Itakura M, Moriyama K, Ohuchi H.; Noji, S.; A missense mutant myostatin causes hyperplasia without hypertrophy in the mouse muscle. Biochemical and Biophysical Research Communications, 2002, 293: 247-251.[88]Lee S J. Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways. PLoS One, 2007, 2: e789. |